A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
ConditionWound
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorSolventum US LLC
About this trial
The purpose of this clinical study is to obtain post-market safety and efficacy data when the V.A.C.® Peel and Place dressing is used in conjunction with 3M™ V.A.C.® Therapy.
Eligibility criteria
Qualifiers
Subject is at least 22 years old at the time of consent.
Subject or legally authorized representative (LAR) is able to provide informed consent.
an open wound: traumatic wound, dehisced surgical wound within 30 days of surgery, burn, venous ulcer, diabetic ulcer, or pressure ulcer Note: Prior to initial placement, the wound may be debrided, as clinically indicated
a closed or covered wound secured with sutures or staples: closed surgical incision, skin flap closure, or skin graft (recipient site)
Disqualifiers
Subject is pregnant or lactating prior to application of the initial dressing. *
Subject is participating in another interventional clinical study or was enrolled in a clinical trial within the last 30 days before screening.
Subject has been diagnosed with a malignancy in the wound.
Subject has untreated osteomyelitis or untreated cellulitis in the wound.
Trial design
Treatments tested in this trial
- 3M™ V.A.C.® Peel and Place Dressing
Treatment groups
90 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov